The macrophage activation marker sMR as a diagnostic and prognostic marker in patients with acute infectious disease with or without sepsis

Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations

(2016) Carolin Fleischmann et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Developing a New Definition and Assessing New Clinical Criteria for Septic Shock

(2016) Manu Shankar-Hari et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Assessment of Clinical Criteria for Sepsis

(2016) Christopher W. Seymour et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

(2016) Mervyn Singer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation

(2016) Tea L. Laursen et al.   LIVER INTERNATIONAL

The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma

(2015) Morten N. Andersen et al.   LEUKEMIA RESEARCH

Increased concentrations of the soluble mannose receptor in serum from patients with pneumococcal bacteraemia, and prediction of survival

(2015) Sidsel Rødgaard-Hansen et al.   Infectious Diseases

Sepsis: Current Dogma and New Perspectives

(2014) Clifford S. Deutschman et al.   IMMUNITY

Mortality Related to Severe Sepsis and Septic Shock Among Critically Ill Patients in Australia and New Zealand, 2000-2012

(2014) Kirsi-Maija Kaukonen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Monocyte Expression and Soluble Levels of the Haemoglobin Receptor (CD163/sCD163) and the Mannose Receptor (MR/sMR) in Septic and Critically Ill Non-Septic ICU Patients

(2014) Anders G. Kjærgaard et al.   PLoS One

Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study

(2013) E. S. Andersen et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Severe Sepsis and Septic Shock

(2013) Derek C. Angus et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epidemiology of severe sepsis

(2013) Florian B Mayr et al.   Virulence

Host innate immune responses to sepsis

(2013) Willem Joost Wiersinga et al.   Virulence

The mannose receptor

(2012) Luisa Martinez-Pomares   JOURNAL OF LEUKOCYTE BIOLOGY

Bacterial Sensing, Cell Signaling, and Modulation of the Immune Response During Sepsis

(2012) Reinaldo Salomao et al.   SHOCK

Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007

(2011) Tara Lagu et al.   CRITICAL CARE MEDICINE

Fungal Recognition Enhances Mannose Receptor Shedding through Dectin-1 Engagement

(2011) Umut Gazi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Epidemiologic Trend of Severe Sepsis in Taiwan From 1997 Through 2006

(2010) Hsiu-Nien Shen et al.   CHEST

New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis

(2010) S. Gaïni et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis

(2010) Theodore J. Iwashyna et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Biomarkers: Diagnosis and Risk Assessment in Sepsis

(2008) Corey E. Ventetuolo et al.   CLINICS IN CHEST MEDICINE